AR013256A1 - DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN. - Google Patents

DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN.

Info

Publication number
AR013256A1
AR013256A1 ARP980103663A ARP980103663A AR013256A1 AR 013256 A1 AR013256 A1 AR 013256A1 AR P980103663 A ARP980103663 A AR P980103663A AR P980103663 A ARP980103663 A AR P980103663A AR 013256 A1 AR013256 A1 AR 013256A1
Authority
AR
Argentina
Prior art keywords
administration
arrangement
capsule
discharge
controlled
Prior art date
Application number
ARP980103663A
Other languages
English (en)
Original Assignee
Intarcia Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intarcia Therapeutics Inc filed Critical Intarcia Therapeutics Inc
Publication of AR013256A1 publication Critical patent/AR013256A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

Una disposicion de descarga para descarga controlada de un agente benéfico, método para formar una disposicion de descarga, método para hacer unadisposicion de descarga y método de controlar una velocidad de liberacion. La disposicion dedescarg a osmotica tiene un tapon de membrana el cual permiteal agua pasar a través del tapon desde un exterior de la cápsula mientras que evita que la composicion de adentro de la cápsula pase afuera de lacápsula. Una velocidad de descargapara la des carga del agente benéfico desde la cápsula de implante es controlada variando un diámetro de nucleo del taponde membrana adentro de una cápsula de diámetro constante. El tapon de membrana tiene una velocidad de penetracion de aguavariable dependi endo de unaextension hasta la cual es comprimido el tapon de membrana por las paredes de la cápsula.
ARP980103663A 1997-12-30 1998-07-24 DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN. AR013256A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7001197P 1997-12-30 1997-12-30

Publications (1)

Publication Number Publication Date
AR013256A1 true AR013256A1 (es) 2000-12-13

Family

ID=22092567

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980103663A AR013256A1 (es) 1997-12-30 1998-07-24 DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN.

Country Status (17)

Country Link
US (1) US6113938A (es)
EP (2) EP1736145B1 (es)
JP (1) JP4494629B2 (es)
KR (1) KR100568917B1 (es)
AR (1) AR013256A1 (es)
AT (2) ATE342051T1 (es)
AU (1) AU8493998A (es)
CA (1) CA2316886C (es)
CY (1) CY1112506T1 (es)
DE (1) DE69836149T2 (es)
DK (1) DK1736145T3 (es)
ES (2) ES2273427T3 (es)
HK (1) HK1031331A1 (es)
PT (2) PT1041974E (es)
TW (1) TW381033B (es)
WO (1) WO1999033449A1 (es)
ZA (1) ZA986627B (es)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY125870A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system flow modulator apparatus and method
WO1999033446A1 (en) * 1997-12-29 1999-07-08 Alza Corporation Osmotic delivery system with membrane plug retention mechanism
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
KR20040007413A (ko) * 2000-11-03 2004-01-24 바이오메디신즈 인코포레이티드 단기 및 장기 약물 약량측정 방법
EP1345588A2 (en) * 2000-12-29 2003-09-24 Bausch & Lomb Incorporated Sustained release drug delivery devices
ES2294043T3 (es) * 2001-01-03 2008-04-01 BAUSCH & LOMB INCORPORATED Dispositivos de liberacion prolongada de medicamentos que comprenden nucleos recubiertos de medicamentos.
ES2320533T3 (es) * 2001-01-03 2009-05-25 BAUSCH & LOMB INCORPORATED Dispositivos de administracion de farmacos de liberacion sostenida con multiples agentes.
US7163688B2 (en) * 2001-06-22 2007-01-16 Alza Corporation Osmotic implant with membrane and membrane retention means
EP1424957A2 (en) * 2001-09-14 2004-06-09 Francis J. Martin Microfabricated nanopore device for sustained release of therapeutic agent
US20030143197A1 (en) * 2001-11-09 2003-07-31 Moran S. Mark Method for treating diseases with omega interferon
BR0311897A (pt) * 2002-06-17 2005-04-05 Alza Corp Sistema de liberação osmótica com mecanismo de potência de impulso de ordem zero inicial compreendendo um agente osmótico disperso no veìculo fluido
US20040059228A1 (en) * 2002-09-23 2004-03-25 Scimed Life Systems, Inc. Systems and methods for flushing catheters
DE60317822D1 (de) * 2002-10-29 2008-01-10 Alza Corp Stabilisierte feste polypeptidpartikel
WO2004056338A2 (en) * 2002-12-19 2004-07-08 Alza Corporation Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device
US7731947B2 (en) * 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
JP2006522133A (ja) * 2003-03-31 2006-09-28 アルザ・コーポレーション 非水性単一相の媒体、及び、そのような媒体を利用するフォーミュレーション
AU2004227985B2 (en) * 2003-03-31 2009-04-02 Intarcia Therapeutics, Inc. Osmotic pump with means for dissipating internal pressure
MXPA05010604A (es) * 2003-03-31 2005-11-23 Alza Corp Sistema de administracion osmotica y metodo para disminuir los tiempos de arranque para sistemas de administracion osmotica.
US20040265351A1 (en) 2003-04-10 2004-12-30 Miller Richard L. Methods and compositions for enhancing immune response
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
US20090208540A1 (en) * 2003-08-11 2009-08-20 Indevus Pharmaceuticals, Inc. Implantable device for the delivery of naltrexone and methods of use thereof
US7858110B2 (en) 2003-08-11 2010-12-28 Endo Pharmaceuticals Solutions, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CA2437639C (en) * 2003-08-11 2016-07-05 Valera Pharmaceuticals, Inc. Long term drug delivery devices with polyurethane based polymers and their manufacture
CN1859900A (zh) * 2003-09-30 2006-11-08 阿尔萨公司 具有递增释放特征的渗透压驱动的活性剂输送装置
MXPA06002030A (es) 2003-10-31 2006-05-17 Alza Corp Bomba osmotica con tapon de membrana de auto-retencion, de rapido inicio.
BRPI0416177A (pt) * 2003-11-06 2007-01-09 Alza Corp redutor de taxa de embebição modular para uso com bomba osmótica implantável
US20050175701A1 (en) * 2004-02-10 2005-08-11 Alza Corporation Capillary moderator for osmotic delivery system
US20050266087A1 (en) * 2004-05-25 2005-12-01 Gunjan Junnarkar Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium
US7117870B2 (en) * 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
US20060045891A1 (en) * 2004-08-24 2006-03-02 Lovalenti Phillip M Density-matched suspension vehicles and pharmaceutical suspensions
US20060134176A1 (en) * 2004-12-22 2006-06-22 Bausch & Lomb Incorporated Pharmaceutical delivery system and method of use
US20060216242A1 (en) * 2005-02-03 2006-09-28 Rohloff Catherine M Suspending vehicles and pharmaceutical suspensions for drug dosage forms
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
JP2008528698A (ja) * 2005-02-03 2008-07-31 インターシア セラピューティクス，インコーポレイティド 埋め込み可能なインターフェロン含有デバイス
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
US20070015689A1 (en) 2005-06-23 2007-01-18 Alza Corporation Complexation of metal ions with polypeptides
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
US7790671B2 (en) * 2005-10-07 2010-09-07 Codman & Shurtleff, Inc. Implantable pump for protein delivery for obesity control by drug infusion into the brain
AU2007266475B2 (en) 2006-05-30 2009-12-03 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
AU2007284759B2 (en) 2006-08-09 2010-10-28 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
CN105688191A (zh) 2007-04-23 2016-06-22 精达制药公司 促胰岛素释放肽的混悬制剂及其应用
FI7960U1 (fi) * 2007-04-27 2008-07-28 Bayer Schering Pharma Oy Implantoitavan annostelusysteemin membraanikuori
DK2240155T3 (da) * 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
KR101707791B1 (ko) * 2008-09-30 2017-02-17 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 리스페리돈 전달용 이식형 장치
EP2344125A1 (en) * 2008-09-30 2011-07-20 Endo Pharmaceuticals Solutions Inc. Implantable device for the delivery of histrelin and methods of use thereof
NZ592113A (en) * 2008-10-15 2012-04-27 Intarcia Therapeutics Inc Highly concentrated drug particles, formulations, suspensions and uses thereof
MX352878B (es) 2009-09-28 2017-12-13 Intarcia Therapeutics Inc Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
AU2010313456A1 (en) 2009-10-30 2012-05-17 Ntf Therapeutics, Inc. Improved neurturin molecules
US8038650B2 (en) * 2010-02-22 2011-10-18 Microsert Ltd. Slow release liquid drug delivery device
AU2011248625B2 (en) 2010-04-26 2017-01-05 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase
US8961960B2 (en) 2010-04-27 2015-02-24 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases
WO2011139853A2 (en) 2010-04-28 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl trna synthetases
JP6008838B2 (ja) 2010-04-29 2016-10-19 エータイアー ファーマ， インコーポレイテッド アスパラギニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US9068177B2 (en) 2010-04-29 2015-06-30 Atyr Pharma, Inc Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases
CN103118693B (zh) 2010-04-29 2017-05-03 Atyr 医药公司 与缬氨酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现
WO2011140135A2 (en) 2010-05-03 2011-11-10 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases
AU2011248227B2 (en) 2010-05-03 2016-12-01 Pangu Biopharma Limited Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases
EP2566515B1 (en) 2010-05-03 2017-08-02 aTyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases
JP6008844B2 (ja) 2010-05-04 2016-10-19 エータイアー ファーマ， インコーポレイテッド ｐ３８ＭＵＬＴＩ−ｔＲＮＡ合成酵素複合体のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
CA2799197C (en) 2010-05-14 2019-10-29 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
CA2799480C (en) 2010-05-17 2020-12-15 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-trna synthetases
CA2800281C (en) 2010-06-01 2021-01-12 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases
CA2804416C (en) 2010-07-12 2020-04-28 Atyr Pharma, Inc. Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
JP5964304B2 (ja) 2010-08-25 2016-08-03 エータイアー ファーマ， インコーポレイテッド チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP2014518210A (ja) * 2011-06-15 2014-07-28 オリエント ファーマ シーオー．，エルティーディー． 多層カプセルおよびその製造方法
EP2861522A1 (en) * 2012-06-14 2015-04-22 Ceramatec, Inc Apparatus and method for delivering beneficial liquids at a consistent rate
CA2896053A1 (en) 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
JP6564369B2 (ja) 2013-12-09 2019-08-21 デュレクト コーポレイション 薬学的活性剤複合体、ポリマー複合体、ならびにこれらを伴う組成物及び方法
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CN113598842A (zh) 2015-06-03 2021-11-05 因塔西亚制药公司 植入物放置和移除***
BR112018008993A2 (pt) 2015-11-05 2018-10-30 Massachusetts Gen Hospital entrega intratecal de sequências de ácidos nucleicos que codificam abcd1 para o tratamento de adrenomieloneuropatia
MX2018014016A (es) 2016-05-16 2019-08-01 Intarcia Therapeutics Inc Polipéptidos selectivos del receptor de glucagón y métodos para utilizarlos.
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
BR112019008021A2 (pt) 2016-10-20 2019-07-09 Peptron, Inc. métodos de distribuição de um polipeptídeo neuroprotetor ao sistema nervoso central
EP3565580B1 (en) 2017-01-03 2024-03-06 i2o Therapeutics, Inc. Continuous administration of exenatide and co-adminstration of acetaminophen, ethinylestradiol or levonorgestrel
KR20190126335A (ko) 2017-03-08 2019-11-11 인타르시아 세라퓨틱스 인코포레이티드 약물 전달 장치로부터 메스꺼움 유발 화합물을 투여하기 위한 장치 및 방법
USD933219S1 (en) 2018-07-13 2021-10-12 Intarcia Therapeutics, Inc. Implant removal tool and assembly
EP3864031A1 (en) 2018-10-11 2021-08-18 Intarcia Therapeutics, Inc. Human amylin analog polypeptides and methods of use
CA3167217A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3995631A (en) * 1971-01-13 1976-12-07 Alza Corporation Osmotic dispenser with means for dispensing active agent responsive to osmotic gradient
US3732865A (en) * 1971-01-13 1973-05-15 Alza Corp Osmotic dispenser
US3995632A (en) * 1973-05-04 1976-12-07 Alza Corporation Osmotic dispenser
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4243030A (en) * 1978-08-18 1981-01-06 Massachusetts Institute Of Technology Implantable programmed microinfusion apparatus
US4373527B1 (en) * 1979-04-27 1995-06-27 Univ Johns Hopkins Implantable programmable medication infusion system
US4340054A (en) * 1980-12-29 1982-07-20 Alza Corporation Dispenser for delivering fluids and solids
US4439196A (en) * 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4552561A (en) * 1982-12-23 1985-11-12 Alza Corporation Body mounted pump housing and pump assembly employing the same
US4639244A (en) * 1983-05-03 1987-01-27 Nabil I. Rizk Implantable electrophoretic pump for ionic drugs and associated methods
US4865845A (en) * 1986-03-21 1989-09-12 Alza Corporation Release rate adjustment of osmotic or diffusional delivery devices
US4874388A (en) * 1987-06-25 1989-10-17 Alza Corporation Multi-layer delivery system
US5151093A (en) * 1990-10-29 1992-09-29 Alza Corporation Osmotically driven syringe with programmable agent delivery
GB9027422D0 (en) * 1990-12-18 1991-02-06 Scras Osmotically driven infusion device
US5137727A (en) * 1991-06-12 1992-08-11 Alza Corporation Delivery device providing beneficial agent stability
US5223265A (en) * 1992-01-10 1993-06-29 Alza Corporation Osmotic device with delayed activation of drug delivery
US5456679A (en) * 1992-02-18 1995-10-10 Alza Corporation Delivery devices with pulsatile effect
US5308348A (en) * 1992-02-18 1994-05-03 Alza Corporation Delivery devices with pulsatile effect
DK1238657T3 (da) * 1996-02-02 2005-01-17 Alza Corp Vedvarende frigivelse af et aktivt middel ved anvendelse af et implanterbart system
MY125849A (en) * 1997-07-25 2006-08-30 Alza Corp Osmotic delivery system, osmotic delivery system semipermeable body assembly, and method for controlling delivery rate of beneficial agents from osmotic delivery systems
CN100388916C (zh) * 1997-12-22 2008-05-21 阿尔扎有限公司 用于控释药物传递装置的速率控制膜

Also Published As

Publication number Publication date
JP4494629B2 (ja) 2010-06-30
TW381033B (en) 2000-02-01
JP2001527035A (ja) 2001-12-25
CY1112506T1 (el) 2015-12-09
US6113938A (en) 2000-09-05
AU8493998A (en) 1999-07-19
EP1041974A1 (en) 2000-10-11
ATE537818T1 (de) 2012-01-15
CA2316886C (en) 2007-09-25
KR100568917B1 (ko) 2006-04-07
ES2378675T3 (es) 2012-04-16
EP1736145B1 (en) 2011-12-21
PT1736145E (pt) 2012-03-16
ATE342051T1 (de) 2006-11-15
WO1999033449A1 (en) 1999-07-08
EP1041974B1 (en) 2006-10-11
ES2273427T3 (es) 2007-05-01
HK1031331A1 (en) 2001-06-15
EP1736145A2 (en) 2006-12-27
DE69836149D1 (de) 2006-11-23
EP1736145A3 (en) 2007-09-12
CA2316886A1 (en) 1999-07-08
ZA986627B (en) 1999-03-05
KR20010033782A (ko) 2001-04-25
DE69836149T2 (de) 2007-08-16
PT1041974E (pt) 2007-01-31
DK1736145T3 (da) 2012-04-10

Similar Documents

Publication Publication Date Title
AR013256A1 (es) DISPOSICIoN DE ADMINISTRACIoN PARA UNA ADMINISTRACIoN CONTROLADA DE UN AGENTE BENÉFICO, MÉTODO PARA FORMAR UNA DISPOSICIoN DE ADMINISTRACIoN , MÉTODO PARA HACER UNA DISPOSICIoN DE ADMINISTRACIoN Y MÉTODO DE CONTROLAR UNA VELOCIDAD DE LIBERACIoN.
ES2179165T3 (es) Liberacion controlada de esteroides a partir de recubrimientos de azucar.
AR026403A1 (es) Sistema para producir un chorro coherente sencillo
AU2003224794A8 (en) Volume efficient controlled release dosage form
BR0108328A (pt) Cartucho
CO4920211A1 (es) Nuevas preparaciones medicamentosas acuosas para la produc cion de aerosoles libres de gar propulsor
WO2001060750A3 (en) Apparatus and method for controlled delivery of a gas
ES2105913T3 (es) Composiciones para el teñido de las fibras queratinicas que comprenden un orto-diamino pirazol y una sal de manganeso, procedimiento de teñido que utiliza estas composiciones.
AR036266A1 (es) Pelicula para refrescar el aliento
AR005156A1 (es) Aparato y metodo de inyeccion ultrasonica de combustible liquido
AU2001242401A1 (en) Mixing capsule
WO2001080825A3 (en) Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
MX9204500A (es) Membranas de fibra hueca.
HRP20041084B1 (en) C-aryl glucoside sglt2 inhibitors and method
UY26938A1 (es) Tratamiento de semillas con recubrimiento que contienen hidrogel
AR021750A1 (es) Aparato para el tratamiento topico localizado de una enfermedad
ES2166988T3 (es) Terapia de administracion uniforme de farmacos.
ES2130793T3 (es) Dispositivo de seguridad.
ES2138739T3 (es) Dispositivo de filtrado para filtrar agua a un sistema de refrigeracion de emergencia en una central nuclear.
AR012103A1 (es) BOQUILLA PARA EXTINCIoN DE INCENDIOS, QUE SE DESCARGA DE UNA CORRIENTE LíQUIDA DE UN MATAFUEGO.
ES2126795T3 (es) Formulacion y procedimiento de control de los nematodos parasitos de las plantas.
SE9600864L (sv) Wobbler
TW430699B (en) Single crystal pulling apparatus
ES2174901T3 (es) Procedimiento de guia de un dispositivo y aparato para guiar un dispositivo en una direccion requerida.
ES2161374T3 (es) Segmento para el revestimiento de recintos huecos.

Legal Events

Date Code Title Description
FG Grant, registration